#Israel #Tel Aviv #HealthTech #Life Science #Biomed Israel

Biomed 2025: A Hub for Global Life Science Collaboration

The much-anticipated Biomed 2025 conference is scheduled to occur from May 20 to May 22, 2025, at the luxurious David InterContinental Hotel in Tel Aviv, Israel. This annual event stands as a premier gathering for the life science and health technology sectors, drawing both local and international leaders to facilitate discussions and forge valuable connections.

Celebrating its 23rd edition, Biomed Israel serves as a significant platform, attracting professionals from various healthcare sectors across the globe. The conference aims to provide a unique opportunity for attendees to explore Israel's rich and innovative landscape in life sciences and biomedicine. More than 100 companies, encompassing cutting-edge startups and established firms, will showcase their groundbreaking products and technologies.

One of the highlights of this conference includes a plenary session featuring an esteemed panel of global bankers and venture capitalists, aptly named The Investment Tango: VCs, Bankers, and the Dance of Deal-Making. Notable participants in this session include:

• - Michael Margolis, Senior Managing Director at Oppenheimer & Co.
• - Michael Rice, Founding Partner at LifeSci Advisors
• - Nick Pachuda, MD, General Partner at Neovate Capital Partners
• - Mitchell Gold, MD at Frazier Life Sciences
• - Jing Bao, MD, PhD from Shanghai HealthCare Capital
• - Craig Yeshion, MD at Perceptive Advisors

Additionally, the conference will feature presentations from prominent figures in the industry, including:

• - Prof. Yitshak Kreiss, Director General at Sheba Medical Center
• - Philippe Gallone, Partner and Head of Healthcare Investment Banking at Goldman Sachs
• - Prof. Yinon Ben Neriah, Israel Prize laureate in Medical Research
• - Dror Bin, CEO of the Israel Innovation Authority
• - Rony Paz, Dean at the Weizmann Institute of Science

Co-chaired by dynamic leaders like Ruti Alon, Ora Dar, and Nissim Darvish, Biomed 2025 isn't just a showcase of innovation but also a platform for profound discussions on the future of healthcare. Alon emphasizes the growth and significance of Biomed over the years:

“Over the past two decades, this conference has emerged as one of the foremost gatherings in the life sciences field, celebrating groundbreaking partnerships and addressing critical medical challenges.”

Ruti Alon highlights that the conference aims to navigate through current healthcare challenges while focusing on innovative strategies that will shape the industry.

The content of this year’s conference is designed to thoroughly examine the critical intersections between technology, medicine, and societal impact, addressing both immediate healthcare issues and overarching trends. Alon concludes by emphasizing the urgency and relevance of topics covered at the event amid ongoing global challenges.

As participants gather in Tel Aviv, they should anticipate not only discovering new business opportunities but also being part of conversations that drive the industry's evolution. Registration is now open, and further information about the preliminary agenda, session heads, and other details can be found through Biomed Israel's official channels.

For inquiries, please contact Tsipi Haitovsky, the Global Media Liaison at Biomed Israel, via email or phone.

The world looks forward to the innovations, networking opportunities, and transformative discussions that will emerge from Biomed 2025, reshaping the healthcare landscape for years to come.